Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans

Ítems similars

• Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects
  per: Dingemanse, Jasper, et al.
  Publicat: (2002)
• Organocatalytic Enantioselective Conjugate Addition of Nitromethane to Benzylidene-2-Benzoyl Acetate: Asymmetric Synthesis of ABT – 627, an Endothelin Receptor Antagonist
  per: Hajra, Saumen, et al.
  Publicat: (2020)
• Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
  per: Sidharta, P. N., et al.
  Publicat: (2015)
• Vasodilator effects of the endothelin ET(A) receptor selective antagonist BMS-193884 in healthy men
  per: Dhaun, Neeraj, et al.
  Publicat: (2005)
• Co-administration of ketoconazole with H(1)-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects
  per: Chaikin, P, et al.
  Publicat: (2005)